6L9.F stock jumped 2400.00% to €0.025 on XETRA intraday trade on 05 Mar 2026, driven by a surge in volume and a relVolume of 12.54. The move follows a multi-month downtrend from a year high of €4.60, leaving trading thin but volatile today. We examine trading metrics, key fundamentals including EPS -0.55 and PE -0.05, sector context for Healthcare in Germany, and short-term price scenarios for ViewRay, Inc. (6L9.F) using Meyka AI market data and technical cues.

Intraday price action and context for 6L9.F stock

Today ViewRay, Inc. (6L9.F) opened at €0.001 and printed an intraday high of €0.025, with the prior close at €0.001. The reported volume of 3,500 versus an average volume of 279 denotes extreme relative activity. This intraday spike accounts for the reported 2400.00% one-month change and is consistent with a short-lived liquidity event rather than a steady trend.

Trading metrics and what the volume means for 6L9.F stock

The stock’s relative volume of 12.54 and average volume of 279 show traders pushed liquidity into a previously thin tape. High relVolume often reflects news, block trades, or short-covering; for 6L9.F stock today, order-book gaps (day low €0.001) increase the likelihood of price whipsaws. Risk managers should note shares outstanding 8,289,130,240 and a market cap of roughly €207,228,256, which magnifies supply-side effects.

Fundamentals and valuation of ViewRay, Inc. for 6L9.F stock

ViewRay operates in Medical – Devices within Healthcare and reports trailing EPS -0.55 and a negative PE of -0.05, highlighting recurring losses. Key ratios show a current ratio 2.36 and debt/equity 1.05, with cash per share 0.752 and book value per share 0.455. Price-to-sales TTM of 2.36 and PB of 0.06 suggest the market prices significant recovery risk into 6L9.F stock.

Technical outlook and realistic 6L9.F stock price targets

Short-term technicals favor caution: the 50-day average €0.31916 and 200-day average €2.71739 sit far above today’s price, indicating a long-term downtrend. We set short-term resistance near €0.04 and a base target at €0.12 if momentum sustains. A recovery to €0.30 would align with the 50-day average range; each level implies outsized percentage moves from €0.025, so stop-loss discipline is essential.

Meyka AI grade and forecast for 6L9.F stock

Meyka AI rates 6L9.F with a score out of 100. Meyka AI rates 6L9.F with a score out of 100: Score 61.55 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term price near €0.04 (≈60.00% implied upside) and a 12-month scenario near €0.30 (≈1100.00% implied upside) versus the current €0.025; forecasts are model-based projections and not guarantees.

Risks and catalysts to watch for 6L9.F stock

Primary risks include low liquidity, continued operating losses, and widening bid-ask spreads that can produce volatile fills for traders. Catalysts that could change the outlook include clinical data, new MRIdian orders, or corporate announcements. Monitor ViewRay investor pages and regulatory updates for firm triggers; thin intraday liquidity makes these events high-impact for 6L9.F stock.

Final Thoughts

Key takeaways for 6L9.F stock: today’s intraday jump to €0.025 and volume surge mark a high-volume mover event, but not a change in the company’s longer-term fundamentals. ViewRay shows cash per share 0.752, EPS -0.55, and mixed liquidity metrics that amplify price moves. Traders should treat today’s action as a volatility event and use tight risk controls. Meyka AI’s forecast model projects a short-term target of €0.04 (≈60.00% upside) and a 12-month scenario of €0.30 (≈1100.00% upside) from the current €0.025; these are model outputs, not guarantees. For further company detail see ViewRay’s site and investor releases, and for live order-book context check the Meyka stock page for 6L9.F. We flag healthcare sector performance and company-specific catalysts as decisive for whether this high-volume move becomes a sustained trend.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.